Anika Therapeutics, Inc. (NASDAQ:ANIK)
| CAPS Rating |
|
|---|---|
| Open | $10.75 |
| Previous Close | $10.75 |
| Daily Range | $10.56 - $10.86 |
| 52-Week Range | $5.24 - $11.67 |
| Market Cap | $144.80M |
| P/E Ratio | 15.90 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 47,617 |
| Average Daily Volume | 0 |
ANIK
VS S&P 500 (SPY)
How do you think ANIK will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ANIK Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ANIK News and Commentary
- Anika Therapeutics CEO Discusses Q2 2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Anika Therapeutics Shares May Rebound – SeekingAlpha
- Anika Therapeutics' CEO Discusses Q1 2011 Results - Earnings Call Transcript – SeekingAlpha
- Anika Therapeutics' CEO Discusses Q1 2011 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- 19 Micro Cap Stocks Being Dumped by Mutual Funds – SeekingAlpha
- Why Did My Stock Just Die? – The Motley Fool
- Can These Stocks Bounce Higher? – The Motley Fool
- Whoa! What Just Happened to My Stock? – The Motley Fool
- Anika Therapeutics CEO Discusses Q4 2010 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Anika Therapeutics CEO Discusses Q4 2010 Results - Earnings Call Transcript – SeekingAlpha
- Wall Street's Best Hidden Stocks – The Motley Fool
- Tomorrow's Monster Stock? – The Motley Fool
- Stocks Down at Mid-Day, But Off Lows, as Investors Digest Mixed Economic Data – NASDAQ
- Mid-Day Update: Stocks Down on Economic Data; Investors Eye NYSE, Deutsche Boerse Deal – NASDAQ
- Anika Therapeutics CEO Discusses Q3 2010 Results – Earnings Call Transcript – SeekingAlpha
- Anika Therapeutics CEO Discusses Q3 2010 Results – Earnings Call Transcript – SeekingAlpha Transcripts
- Anika Therapeutics, Inc. Q2 2010 Earnings Call Transcript – SeekingAlpha Transcripts
- Anika Therapeutics, Inc. Q2 2010 Earnings Call Transcript – SeekingAlpha
- UPDATE 1-Anika buys Italian firm's unit for $34 mln – Reuters
- HEADLINE STOCKS-U.S. small/midcap stocks on the move on Oct 28 – Reuters
RSS Headlines
Fool UK
